HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a
team of industry experts to ensure accuracy.
All articles are edited and checked for factual accuracy by our
Editorial Team prior to being published.
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
(HealthDayNews) -- Giggle incontinence is the second-most common type of childhood enuresis and has always been very difficult to treat. For a long time, there was nothing to do but tell a child to think unhappy thoughts.
But neurologists at the University of Minnesota Medical School determined that giggle incontinence is caused by a central nervous system problem. They reported in the Journal of Urology that giggle incontinence responds very well to methylphenidate, better known as Ritalin.
Methylphenidate is best known as a treatment for attention deficit disorder, but was originally used as a stimulant.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at solutions@healthday.com with any questions.
